Skip to content
GLP-1 Scorecard
Menu
Graded #238

Options Medical Weight Loss

Options Medical Weight Loss offers telehealth medical weight-loss programs built around compounded GLP-1 — semaglutide starting around $239/month and tirzepatide from $299/month, plus NAD+ injections at $199/month.

Visit Options Medical Weight Loss ↗We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$199/mo (compounded)
Tirzepatide
$399/mo (compounded)
Coverage
Coverage not published
Brand-name
Yes

Weigh Options Medical Weight Loss against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value54/100
Dose & formulation77/100
Clinical oversight81/100
Labs & monitoring53/100
Fulfillment67/100
Contract terms55/100

Strengths

  • LegitScript certified with clear, upfront program pricing
  • Compounded semaglutide (~$239) and tirzepatide (from $299), plus NAD+
  • Structured metabolic-health program with provider support and accountability
  • HSA/FSA eligible with flexible payment options

Where it loses points

  • Doesn't clearly publish which states its telehealth covers
  • Tirzepatide tiers climb to $339-$399/month
  • More program structure (and cost) than medication-only sellers
  • Compounded GLP-1 only online — no brand-name options noted

Bottom line — Grade C

Best for: People wanting a structured medical weight-loss program with compounded GLP-1 and provider accountability.

Ranked #238 of 544 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Visit Options Medical Weight Loss ↗

Closest here

The rankings grading nearest Options Medical Weight Loss — the realistic shortlist.

Healthicare#236

Healthicare is a GLP-1 telehealth platform offering both compounded options and a full brand-name menu — Ozempic, Wegovy, Mounjaro, and Zepbound — on a single account.

NowPatient#237

NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

Primary Clinic (Direct GLP)#239

Primary Clinic (Direct GLP) is a Direct Primary Care membership rather than the usual direct-to-consumer GLP-1 marketplace.

Shapely#240

Shapely is a GLP-1 telehealth platform founded by Dr. Justin Zaghi, MD/MBA, a Harvard-trained physician board-certified in both internal medicine and obesity medicine.

Enara Health#241

Enara Health (enarahealth.com), founded 2015 in San Mateo, CA, is a physician-led, insurance-based obesity medicine program that prescribes branded GLP-1 medications including Wegovy (semaglutide) and Zepbound (tirzepatide), alongside dietitian counseling, health coaching, metabolic testing, and behavioral support.

RestorLife Med#242

RestorLife Med is a physician-guided GLP-1 telehealth practice (founder Dr. Michael Wasef, MD, licensed in all 50 states) offering compounded semaglutide and tirzepatide for weight loss, including microdose entry options.

The 20 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Options Medical Weight Loss's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Options Medical Weight Loss's site. Not medical advice; see our disclosure.

← Back to the scorecard